Bristol-Myers Squibb (BMY) Tops Q1 EPS by 1c, Maintains EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $61.01 -1.09%
EPS Growth %: -33.1%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -33.1%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.10, $0.01 better than the analyst estimate of $1.09. Revenue for the quarter came in at $5.92 billion versus the consensus estimate of $5.76 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.10-$4.20, versus the consensus of $4.19.
- Worldwide revenues increasing in the mid-single digits.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Community Trust Bancorp (CTBI) Misses Q3 EPS by 22c
- Danaher (DHR) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
